00000nam 2200000zi 4500 9.933602 CaOODSP 20240222171343 m o d f cr mn||||||||| 240207e202201##onc o f000 0 eng d CaOODSP eng rda CaOODSP n-cn--- HP5-221/2022E-PDF Evaluation of the evidence for health promotion, chronic disease and injury prevention program : focus on COVID-19 activities / prepared by: Office of Audit and Evaluation Health Canada and the Public Health Agency of Canada. [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, January 2022. 1 online resource (iv, 24 pages) : illustrations, maps text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. Issued also in French under title: Évaluation des données probantes liées à la promotion de la santé et à la prévention des maladies chroniques et des blessures : accent sur les activités liées à la COVID-19. Includes bibliographical references (pages 23-24). "The Evidence for Health Promotion, Chronic Disease and Injury Prevention Program (Evidence Program), situated within PHAC’s Health Promotion and Chronic Disease Prevention Branch (HPCDPB), is an important player in understanding the wider impact of the COVID-19 pandemic on various groups. The Evidence Program, led by the Centre for Surveillance and Applied Research (CSAR), collects and analyzes national surveillance data on maternal, child/youth, and seniors’ health; chronic diseases and conditions; injuries; health inequalities; and the associated social, behavioural, and environmental determinants of health. It also carries out research to build a strong evidence base for action on public health. The Evidence Program is responsible for providing information to a broad range of stakeholders, including government senior leadership, Special Advisory Committees, national working groups, and the Canadian public"--Executive summary, page ii. Public Health Agency of Canada. Office of Audit and Evaluation. Health promotion Government policy Canada Evaluation. Chronic diseases Canada Evaluation. Post COVID-19 condition (Disease) Diagnosis Canada. Canada. Health Canada. Office of Audit and Evaluation, issuing body. Public Health Agency of Canada, issuing body. Évaluation des données probantes liées à la promotion de la santé et à la prévention des maladies chroniques et des blessures : (CaOODSP)9.934300 PDF 898 KB https://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-221-2022-eng.pdf HTML N/A https://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/evidence-health-promotion-chronic-disease-injury-prevention-program-2022.html